
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
        <meta name="description" content="Clinical decision support for vascular dementia diagnosis, vascular risk factor modification, symptomatic treatment, and secondary stroke prevention">
      
      
      
        <link rel="canonical" href="https://blondarb.github.io/neuro-plans/drafts/vascular-dementia/">
      
      
      
      
        
      
      
      <link rel="icon" href="../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.7.1">
    
    
      
        <title>Vascular Dementia - Neuro Clinical Plans</title>
      
    
    
      <link rel="stylesheet" href="../../assets/stylesheets/main.484c7ddc.min.css">
      
        
        <link rel="stylesheet" href="../../assets/stylesheets/palette.ab4e12ef.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../assets/css/custom.css">
    
    <script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#vascular-dementia" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../.." title="Neuro Clinical Plans" class="md-header__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Neuro Clinical Plans
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Vascular Dementia
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a4 4 0 0 0-4 4 4 4 0 0 0 4 4 4 4 0 0 0 4-4 4 4 0 0 0-4-4m0 10a6 6 0 0 1-6-6 6 6 0 0 1 6-6 6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 18c-.89 0-1.74-.2-2.5-.55C11.56 16.5 13 14.42 13 12s-1.44-4.5-3.5-5.45C10.26 6.2 11.11 6 12 6a6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var palette=__md_get("__palette");if(palette&&palette.color){if("(prefers-color-scheme)"===palette.color.media){var media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']");palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent")}for(var[key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      
      
        <label class="md-header__button md-icon" for="__search">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        </label>
        <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
        <div class="md-search__suggest" data-md-component="search-suggest"></div>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
      
    
    
      <div class="md-header__source">
        <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../.." title="Neuro Clinical Plans" class="md-nav__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    Neuro Clinical Plans
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../.." class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Home
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../clinical/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Interactive Clinical Tool
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3" >
        
          
          <label class="md-nav__link" for="__nav_3" id="__nav_3_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    Clinical Plans
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Clinical Plans
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Overview
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_2" >
        
          
          <label class="md-nav__link" for="__nav_3_2" id="__nav_3_2_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Seizures & Epilepsy
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_2">
            <span class="md-nav__icon md-icon"></span>
            
  
    Seizures & Epilepsy
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/status-epilepticus/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Status Epilepticus
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/new-onset-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    New Onset Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/breakthrough-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Breakthrough Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_3" >
        
          
          <label class="md-nav__link" for="__nav_3_3" id="__nav_3_3_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Stroke & Vascular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Stroke & Vascular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/acute-ischemic-stroke/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Ischemic Stroke
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/transient-ischemic-attack/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Transient Ischemic Attack
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/intracerebral-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Intracerebral Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/subarachnoid-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Subarachnoid Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_4" >
        
          
          <label class="md-nav__link" for="__nav_3_4" id="__nav_3_4_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuromuscular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/guillain-barre-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Guillain-Barré Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/myasthenia-gravis-crisis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenic Crisis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/myasthenia-gravis-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenia Gravis - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/neuromuscular-respiratory-failure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular Respiratory Failure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/peripheral-neuropathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Peripheral Neuropathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_5" >
        
          
          <label class="md-nav__link" for="__nav_3_5" id="__nav_3_5_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    CNS Infections
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_5_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_5">
            <span class="md-nav__icon md-icon"></span>
            
  
    CNS Infections
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/bacterial-meningitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bacterial Meningitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/hsv-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    HSV Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/autoimmune-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Autoimmune Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_6" >
        
          
          <label class="md-nav__link" for="__nav_3_6" id="__nav_3_6_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Spinal Emergencies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_6_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_6">
            <span class="md-nav__icon md-icon"></span>
            
  
    Spinal Emergencies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/acute-myelopathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Myelopathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/spinal-cord-compression-malignant/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Spinal Cord Compression (Malignant)
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/cauda-equina-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Cauda Equina Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/epidural-abscess/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Epidural Abscess
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_7" >
        
          
          <label class="md-nav__link" for="__nav_3_7" id="__nav_3_7_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuro-Oncology
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_7_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_7">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuro-Oncology
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/brain-metastases/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Brain Metastases
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_8" >
        
          
          <label class="md-nav__link" for="__nav_3_8" id="__nav_3_8_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Critical Care
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_8_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_8">
            <span class="md-nav__icon md-icon"></span>
            
  
    Critical Care
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/elevated-icp-management/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Elevated ICP Management
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_9" >
        
          
          <label class="md-nav__link" for="__nav_3_9" id="__nav_3_9_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Demyelinating
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_9_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_9">
            <span class="md-nav__icon md-icon"></span>
            
  
    Demyelinating
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/ms-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    MS New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_10" >
        
          
          <label class="md-nav__link" for="__nav_3_10" id="__nav_3_10_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Other
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_10_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_10">
            <span class="md-nav__icon md-icon"></span>
            
  
    Other
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/rapidly-progressive-dementia/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Rapidly Progressive Dementia
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/vertigo-dizziness-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Vertigo / Dizziness
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_4" >
        
          
          <label class="md-nav__link" for="__nav_4" id="__nav_4_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    References
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    References
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/lp-reference/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    LP Reference
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/tracker/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Template Tracker
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#section-a-action-items" class="md-nav__link">
    <span class="md-ellipsis">
      
        SECTION A: ACTION ITEMS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#1-laboratory-workup" class="md-nav__link">
    <span class="md-ellipsis">
      
        1. LABORATORY WORKUP
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2-diagnostic-imaging-studies" class="md-nav__link">
    <span class="md-ellipsis">
      
        2. DIAGNOSTIC IMAGING &amp; STUDIES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3-treatment" class="md-nav__link">
    <span class="md-ellipsis">
      
        3. TREATMENT
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4-other-recommendations" class="md-nav__link">
    <span class="md-ellipsis">
      
        4. OTHER RECOMMENDATIONS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#section-b-reference" class="md-nav__link">
    <span class="md-ellipsis">
      
        SECTION B: REFERENCE
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5-differential-diagnosis" class="md-nav__link">
    <span class="md-ellipsis">
      
        5. DIFFERENTIAL DIAGNOSIS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6-monitoring-parameters" class="md-nav__link">
    <span class="md-ellipsis">
      
        6. MONITORING PARAMETERS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#7-disposition-criteria" class="md-nav__link">
    <span class="md-ellipsis">
      
        7. DISPOSITION CRITERIA
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#8-evidence-references" class="md-nav__link">
    <span class="md-ellipsis">
      
        8. EVIDENCE &amp; REFERENCES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#change-log" class="md-nav__link">
    <span class="md-ellipsis">
      
        CHANGE LOG
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-a-ninds-airen-diagnostic-criteria-for-vascular-dementia" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX A: NINDS-AIREN Diagnostic Criteria for Vascular Dementia
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-b-neuroimaging-findings-in-vascular-dementia" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX B: Neuroimaging Findings in Vascular Dementia
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-c-differentiating-vascular-dementia-from-alzheimers-disease" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX C: Differentiating Vascular Dementia from Alzheimer's Disease
      
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              
              <article class="md-content__inner md-typeset">
                
                  

  <nav class="md-tags" >
    
      
      
      
      
        <a href="../../tags/#tag:cerebrovascular" class="md-tag">cerebrovascular</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:cognitive" class="md-tag">cognitive</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:dementia" class="md-tag">dementia</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:outpatient" class="md-tag">outpatient</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:vascular" class="md-tag">vascular</a>
      
    
  </nav>


  
  


<div class="draft-warning-banner">
  <div class="icon">⚠️</div>
  <div class="content">
    <div class="title">DRAFT - Pending Review</div>
    <div class="description">This plan requires physician review before clinical use.</div>
  </div>
</div>

<h1 id="vascular-dementia">Vascular Dementia<a class="headerlink" href="#vascular-dementia" title="Permanent link">&para;</a></h1>
<p><strong>DIAGNOSIS:</strong> Vascular Dementia
<strong>ICD-10:</strong> F01.50 (Vascular dementia without behavioral disturbance); F01.51 (Vascular dementia with behavioral disturbance); I67.3 (Progressive vascular leukoencephalopathy - Binswanger disease); I67.89 (Other cerebrovascular disease)
<strong>SCOPE:</strong> Diagnosis using NINDS-AIREN and DSM-5 criteria, neuroimaging evaluation for strategic infarcts and white matter disease, vascular risk factor modification, secondary stroke prevention, cholinesterase inhibitors for cognitive symptoms, and management of post-stroke depression, apathy, and behavioral symptoms. Primarily outpatient-focused with coverage for ED and hospital presentations.</p>
<p><strong>STATUS:</strong> Draft - Pending Review</p>
<hr />
<p><strong>PRIORITY KEY:</strong> STAT = Immediate | URGENT = Within hours | ROUTINE = Standard | EXT = Extended/atypical cases | - = Not applicable to this setting</p>
<hr />
<h2 id="section-a-action-items">SECTION A: ACTION ITEMS<a class="headerlink" href="#section-a-action-items" title="Permanent link">&para;</a></h2>
<hr />
<h2 id="1-laboratory-workup">1. LABORATORY WORKUP<a class="headerlink" href="#1-laboratory-workup" title="Permanent link">&para;</a></h2>
<h3 id="1a-essentialcore-labs-reversible-causes-and-vascular-risk-factors">1A. Essential/Core Labs (Reversible Causes and Vascular Risk Factors)<a class="headerlink" href="#1a-essentialcore-labs-reversible-causes-and-vascular-risk-factors" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>CBC with differential</td>
<td>Polycythemia, anemia, infection affecting cognition</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>BMP (Na, K, BUN, Cr, glucose)</td>
<td>Metabolic causes of confusion; renal function for medication dosing</td>
<td>Normal electrolytes, renal function</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>TSH</td>
<td>Hypothyroidism is reversible cause of cognitive impairment</td>
<td>0.4-4.0 mIU/L</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Vitamin B12</td>
<td>Deficiency causes reversible cognitive decline and may worsen vascular dementia</td>
<td>&gt;300 pg/mL (&gt;400 optimal)</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Folate</td>
<td>Deficiency contributes to hyperhomocysteinemia and cognitive impairment</td>
<td>&gt;3 ng/mL</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Hemoglobin A1c</td>
<td>Diabetes is major vascular risk factor; assess chronic glucose control</td>
<td>&lt;7.0% (individualized 7-8% in frail elderly)</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Fasting lipid panel</td>
<td>Assess LDL for secondary stroke prevention; target &lt;70 mg/dL</td>
<td>LDL &lt;70 mg/dL</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Urinalysis</td>
<td>UTI common cause of acute confusion in elderly</td>
<td>Negative for infection</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>PT/INR, PTT</td>
<td>Baseline coagulation; assess if on anticoagulation</td>
<td>Normal or therapeutic</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="1b-extended-workup-second-line">1B. Extended Workup (Second-line)<a class="headerlink" href="#1b-extended-workup-second-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Homocysteine</td>
<td>Elevated levels increase stroke risk and contribute to vascular dementia</td>
<td>&lt;15 μmol/L</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Lipoprotein(a)</td>
<td>Independent cardiovascular risk marker; elevated increases stroke risk</td>
<td>&lt;50 nmol/L (or &lt;30 mg/dL)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>hsCRP</td>
<td>Inflammatory marker; elevated predicts vascular events</td>
<td>&lt;2 mg/L</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Vitamin D, 25-hydroxy</td>
<td>Deficiency associated with cognitive decline and vascular disease</td>
<td>&gt;30 ng/mL</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>RPR or VDRL</td>
<td>Neurosyphilis is treatable cause of dementia</td>
<td>Nonreactive</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>HIV testing</td>
<td>HIV-associated neurocognitive disorder if risk factors</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Hepatic panel (AST, ALT, albumin)</td>
<td>Hepatic encephalopathy; nutritional status; statin safety</td>
<td>Normal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>BNP/NT-proBNP</td>
<td>Heart failure; atrial fibrillation risk assessment</td>
<td>Age-adjusted normal</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Uric acid</td>
<td>Elevated associated with increased stroke and dementia risk</td>
<td>&lt;6 mg/dL</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="1c-rarespecialized-refractory-or-atypical">1C. Rare/Specialized (Refractory or Atypical)<a class="headerlink" href="#1c-rarespecialized-refractory-or-atypical" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>APOE genotyping</td>
<td>Risk stratification; mixed AD/VaD assessment</td>
<td>APOE status for prognosis</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Hypercoagulability panel</td>
<td>Age &lt;50, cryptogenic strokes, recurrent events</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Antiphospholipid antibodies</td>
<td>Lupus anticoagulant, anticardiolipin; young-onset vascular disease</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>ESR, ANA</td>
<td>Suspected CNS vasculitis causing multi-infarct state</td>
<td>Normal/Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>ANCA panel</td>
<td>Vasculitis workup if suspected</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Fabry disease testing (alpha-galactosidase A)</td>
<td>Young-onset stroke; angiokeratomas; neuropathy</td>
<td>Normal enzyme activity</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>NOTCH3 genetic testing</td>
<td>Suspected CADASIL (family history, migraine, early WM disease)</td>
<td>No pathogenic mutation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Mitochondrial DNA analysis</td>
<td>Suspected MELAS or mitochondrial disease</td>
<td>No pathogenic mutation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="2-diagnostic-imaging-studies">2. DIAGNOSTIC IMAGING &amp; STUDIES<a class="headerlink" href="#2-diagnostic-imaging-studies" title="Permanent link">&para;</a></h2>
<h3 id="2a-essentialfirst-line">2A. Essential/First-line<a class="headerlink" href="#2a-essentialfirst-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRI Brain without contrast</td>
<td>At initial evaluation</td>
<td>Strategic infarcts (thalamus, basal ganglia, angular gyrus); confluent white matter hyperintensities (Fazekas ≥2); lacunar infarcts</td>
<td>MRI-incompatible devices, severe claustrophobia</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CT Head non-contrast</td>
<td>If MRI unavailable or contraindicated</td>
<td>Rule out hemorrhage, mass, hydrocephalus; may show old infarcts, leukoaraiosis</td>
<td>None</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>MRA Head and Neck</td>
<td>With initial MRI</td>
<td>Intracranial and extracranial atherosclerosis; assess for stenosis &gt;50%</td>
<td>MRI contraindications</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CTA Head and Neck</td>
<td>Alternative to MRA</td>
<td>Vascular stenosis; atherosclerotic burden</td>
<td>Contrast allergy, CKD (relative)</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Carotid duplex ultrasound</td>
<td>Within 1 week of diagnosis</td>
<td>Assess carotid stenosis; plaque characterization</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>ECG (12-lead)</td>
<td>At diagnosis</td>
<td>Assess for atrial fibrillation, LVH, prior MI</td>
<td>None</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Transthoracic echocardiogram</td>
<td>Within 2 weeks</td>
<td>LV function; valvular disease; intracardiac thrombus</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="2b-extended">2B. Extended<a class="headerlink" href="#2b-extended" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRI Brain with SWI/GRE sequences</td>
<td>With initial MRI</td>
<td>Microbleeds (cerebral amyloid angiopathy pattern vs hypertensive); hemosiderin</td>
<td>MRI contraindications</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>MRI volumetrics</td>
<td>Baseline for progression</td>
<td>Quantify white matter lesion volume; global and regional atrophy</td>
<td>MRI contraindications</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>FDG-PET Brain</td>
<td>Differentiate VaD from AD; atypical cases</td>
<td>Scattered hypometabolism (vs temporoparietal in AD)</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Amyloid PET</td>
<td>Distinguish pure VaD from mixed AD/VaD</td>
<td>Negative suggests pure VaD; positive suggests mixed pathology</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Cardiac telemetry/Holter monitor</td>
<td>Screen for paroxysmal AF</td>
<td>Sinus rhythm; detect occult AF</td>
<td>None</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Extended cardiac monitoring (14-30 day)</td>
<td>Cryptogenic strokes; suspected occult AF</td>
<td>Sinus rhythm; detect paroxysmal AF</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>EEG</td>
<td>Encephalopathy; seizures; rapid decline</td>
<td>Non-specific slowing (not CJD pattern)</td>
<td>None</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Sleep study (polysomnography)</td>
<td>Sleep apnea is vascular risk factor; assess for OSA</td>
<td>AHI &lt;5 (or treat if elevated)</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="2c-rarespecialized">2C. Rare/Specialized<a class="headerlink" href="#2c-rarespecialized" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vessel wall MRI</td>
<td>Suspected CNS vasculitis or reversible vasoconstriction</td>
<td>No vessel wall enhancement or thickening</td>
<td>MRI contraindications</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>DSA (cerebral angiogram)</td>
<td>Vasculitis confirmation; moyamoya; intracranial stenosis</td>
<td>Define vascular anatomy</td>
<td>Contrast allergy, bleeding risk</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>SPECT (perfusion)</td>
<td>Alternative to PET if unavailable</td>
<td>Regional hypoperfusion patterns</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Transesophageal echocardiogram</td>
<td>Cryptogenic strokes; suspected aortic arch atheroma or PFO</td>
<td>No embolic source</td>
<td>Esophageal pathology</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h3 id="lumbar-puncture">LUMBAR PUNCTURE<a class="headerlink" href="#lumbar-puncture" title="Permanent link">&para;</a></h3>
<p><strong>Indication:</strong> Atypical presentation; rapid progression; suspected CNS vasculitis or infection; young-onset (&lt;65); differentiate from AD or inflammatory causes
<strong>Timing:</strong> ROUTINE for diagnostic clarification; URGENT if infectious or inflammatory etiology suspected
<strong>Volume Required:</strong> 10-15 mL standard diagnostic</p>
<table>
<thead>
<tr>
<th>Study</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cell count, protein, glucose</td>
<td>Rule out infection, inflammation, vasculitis</td>
<td>WBC &lt;5, protein &lt;45 mg/dL, glucose &gt;60% serum</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CSF Aβ42 and Aβ42/Aβ40 ratio</td>
<td>Differentiate from Alzheimer's disease</td>
<td>Normal Aβ42 in pure VaD; low suggests mixed AD/VaD</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CSF total tau and p-tau181</td>
<td>Elevated in AD; can help distinguish VaD from AD</td>
<td>Normal or mildly elevated in pure VaD; high p-tau suggests AD</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CSF NfL (neurofilament light)</td>
<td>Non-specific marker of neuronal damage; elevated in vascular injury</td>
<td>Elevated suggests ongoing neurodegeneration</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Oligoclonal bands, IgG index</td>
<td>Rule out inflammatory/demyelinating disease</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>VDRL</td>
<td>Neurosyphilis</td>
<td>Nonreactive</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Autoimmune encephalitis panel</td>
<td>Atypical presentation; subacute onset</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<p><strong>Special Handling:</strong> CSF biomarkers require polypropylene tubes; freeze within 1 hour; send to qualified reference lab
<strong>Contraindications:</strong> Coagulopathy (INR &gt;1.5, platelets &lt;50k); mass effect on imaging; skin infection at puncture site</p>
<hr />
<h2 id="3-treatment">3. TREATMENT<a class="headerlink" href="#3-treatment" title="Permanent link">&para;</a></h2>
<h3 id="3a-acuteemergent">3A. Acute/Emergent<a class="headerlink" href="#3a-acuteemergent" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Treat reversible causes</td>
<td>Various</td>
<td>Identified metabolic or infectious etiology</td>
<td>Per specific cause :: Various :: :: Correct hyponatremia slowly, treat UTI, replace B12, treat hypothyroidism</td>
<td>Depends on intervention</td>
<td>Cognitive reassessment after treatment</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Thiamine</td>
<td>IV/PO</td>
<td>Suspected Wernicke's; alcoholism; malnutrition</td>
<td>500 mg IV TID x 3 days; 100 mg PO daily :: IV/PO :: :: 500 mg IV TID x 3 days if Wernicke suspected; then 100 mg PO daily maintenance</td>
<td>None</td>
<td>Clinical improvement in confusion</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Aspirin</td>
<td>PO</td>
<td>Immediate antiplatelet therapy for secondary stroke prevention</td>
<td>325 mg PO x1 load; 81 mg PO daily :: PO :: :: 325 mg loading dose if no recent stroke, then 81 mg daily ongoing</td>
<td>Active GI bleed; aspirin allergy</td>
<td>GI symptoms, bleeding</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Blood pressure management (acute)</td>
<td>Various</td>
<td>Acute delirium or new stroke</td>
<td>Target &lt;180/110 acutely :: Various :: :: Do NOT lower BP aggressively unless &gt;220/120 or end-organ damage; permissive hypertension first 24-48h of stroke</td>
<td>Symptomatic hypotension</td>
<td>BP q1h initially</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3b-vascular-risk-factor-modification-secondary-stroke-prevention">3B. Vascular Risk Factor Modification (Secondary Stroke Prevention)<a class="headerlink" href="#3b-vascular-risk-factor-modification-secondary-stroke-prevention" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Atorvastatin</td>
<td>PO</td>
<td>High-intensity statin for secondary stroke prevention; LDL target &lt;70</td>
<td>40 mg daily; 80 mg daily :: PO :: :: Start 40-80 mg daily; target LDL &lt;70 mg/dL; 80 mg preferred for established vascular disease</td>
<td>Active liver disease; pregnancy</td>
<td>LFTs at baseline, 6-12 weeks, then annually; myalgias</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Rosuvastatin</td>
<td>PO</td>
<td>Alternative high-intensity statin; may be better tolerated</td>
<td>20 mg daily; 40 mg daily :: PO :: :: Start 20 mg daily; max 40 mg; potent LDL lowering</td>
<td>Active liver disease; pregnancy; Asian dose adjustment (10 mg start)</td>
<td>LFTs; myalgias; CK if symptomatic</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Aspirin (long-term)</td>
<td>PO</td>
<td>Lifelong antiplatelet for secondary stroke prevention</td>
<td>81 mg daily :: PO :: :: 81 mg daily indefinitely for non-cardioembolic vascular dementia</td>
<td>Active GI bleeding; aspirin allergy</td>
<td>GI symptoms; annual CBC</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Clopidogrel</td>
<td>PO</td>
<td>Alternative to aspirin if aspirin-intolerant; or after DAPT period</td>
<td>75 mg daily :: PO :: :: 75 mg daily; may use instead of aspirin if intolerant</td>
<td>Active bleeding</td>
<td>Bleeding signs</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Lisinopril</td>
<td>PO</td>
<td>Blood pressure control; target &lt;130/80 for secondary prevention</td>
<td>5 mg daily; 10 mg daily; 20 mg daily; 40 mg daily :: PO :: :: Start 5-10 mg daily; titrate to goal BP &lt;130/80; max 40 mg daily</td>
<td>Angioedema history; pregnancy; bilateral RAS; hyperkalemia</td>
<td>K+, Cr at 1-2 weeks; BP</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Amlodipine</td>
<td>PO</td>
<td>BP control; add-on or alternative antihypertensive</td>
<td>5 mg daily; 10 mg daily :: PO :: :: Start 5 mg daily; may increase to 10 mg daily</td>
<td>Severe aortic stenosis (relative)</td>
<td>Peripheral edema; BP</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Chlorthalidone</td>
<td>PO</td>
<td>Thiazide-like diuretic for BP control; effective for stroke prevention</td>
<td>12.5 mg daily; 25 mg daily :: PO :: :: Start 12.5 mg daily; may increase to 25 mg daily</td>
<td>Severe hypokalemia; hyponatremia</td>
<td>K+, Na+, uric acid, glucose</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Metformin</td>
<td>PO</td>
<td>First-line for type 2 diabetes if eGFR &gt;30</td>
<td>500 mg daily; 500 mg BID; 1000 mg BID :: PO :: :: Start 500 mg daily with meal; titrate by 500 mg weekly; max 2000-2550 mg/day in divided doses</td>
<td>eGFR &lt;30; acute illness; contrast within 48h</td>
<td>eGFR; B12 annually; lactic acidosis symptoms</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Empagliflozin</td>
<td>PO</td>
<td>SGLT2 inhibitor for diabetes with cardiovascular benefit</td>
<td>10 mg daily; 25 mg daily :: PO :: :: Start 10 mg daily; may increase to 25 mg; cardiovascular mortality benefit</td>
<td>eGFR &lt;20; Type 1 DM; DKA history</td>
<td>eGFR; volume status; genital infections</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Ezetimibe</td>
<td>PO</td>
<td>Add-on for LDL not at goal on statin</td>
<td>10 mg daily :: PO :: :: 10 mg daily with or without food</td>
<td>Severe hepatic impairment</td>
<td>LDL; LFTs</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Apixaban</td>
<td>PO</td>
<td>Atrial fibrillation-related vascular dementia</td>
<td>5 mg BID; 2.5 mg BID :: PO :: :: 5 mg BID (2.5 mg BID if ≥2 of: age ≥80, weight ≤60 kg, Cr ≥1.5)</td>
<td>Active major bleeding; mechanical valve</td>
<td>CrCl; bleeding signs</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Rivaroxaban</td>
<td>PO</td>
<td>AF-related vascular dementia</td>
<td>20 mg daily; 15 mg daily :: PO :: :: 20 mg daily with dinner (15 mg if CrCl 15-50)</td>
<td>Active bleeding; mechanical valve</td>
<td>CrCl; bleeding</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Warfarin</td>
<td>PO</td>
<td>Mechanical valve; select hypercoagulable states; AF if DOACs contraindicated</td>
<td>2-10 mg daily adjusted :: PO :: :: Start 5 mg daily; adjust to INR 2-3</td>
<td>Active bleeding; frequent falls; poor adherence</td>
<td>INR weekly then monthly</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3c-cholinesterase-inhibitors-cognitive-enhancement-modest-benefit">3C. Cholinesterase Inhibitors (Cognitive Enhancement - Modest Benefit)<a class="headerlink" href="#3c-cholinesterase-inhibitors-cognitive-enhancement-modest-benefit" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Donepezil (Aricept)</td>
<td>PO</td>
<td>Vascular dementia cognitive symptoms; modest but measurable benefit</td>
<td>5 mg qHS; 10 mg qHS :: PO :: :: Start 5 mg qHS x 4-6 weeks; if tolerated, increase to 10 mg qHS; benefit smaller than in AD</td>
<td>Sick sinus syndrome; second/third degree heart block without pacemaker; active GI bleeding</td>
<td>Heart rate; GI symptoms (nausea, diarrhea); vivid dreams</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Rivastigmine oral (Exelon)</td>
<td>PO</td>
<td>Vascular dementia; executive dysfunction; may help mixed AD/VaD</td>
<td>1.5 mg BID; 3 mg BID; 4.5 mg BID; 6 mg BID :: PO :: :: Start 1.5 mg BID with meals; increase by 1.5 mg BID every 2 weeks; target 6 mg BID</td>
<td>Sick sinus; severe hepatic impairment</td>
<td>GI symptoms; weight loss; bradycardia</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Rivastigmine patch (Exelon Patch)</td>
<td>TD</td>
<td>Vascular dementia; better GI tolerability than oral</td>
<td>4.6 mg/24hr; 9.5 mg/24hr; 13.3 mg/24hr :: TD :: :: Start 4.6 mg/24hr patch; increase every 4 weeks; target 9.5-13.3 mg/24hr</td>
<td>Same as oral</td>
<td>Skin irritation; rotate sites</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Galantamine (Razadyne)</td>
<td>PO</td>
<td>Vascular dementia; dual mechanism may benefit executive function</td>
<td>4 mg BID; 8 mg BID; 12 mg BID :: PO :: :: Start 4 mg BID with meals x 4 weeks; increase to 8 mg BID x 4 weeks; target 8-12 mg BID</td>
<td>Sick sinus; severe renal impairment (CrCl &lt;9); severe hepatic impairment</td>
<td>GI symptoms; bradycardia</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Memantine (Namenda)</td>
<td>PO</td>
<td>Moderate-severe vascular dementia; add to cholinesterase inhibitor</td>
<td>5 mg daily; 5 mg BID; 10 mg BID :: PO :: :: Start 5 mg daily x 1 week; increase by 5 mg/week: 5 mg BID, then 5/10 mg, then 10 mg BID</td>
<td>Severe renal impairment (reduce dose if CrCl 5-29: max 5 mg BID)</td>
<td>Confusion, dizziness, constipation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3d-post-stroke-depression-and-apathy">3D. Post-Stroke Depression and Apathy<a class="headerlink" href="#3d-post-stroke-depression-and-apathy" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sertraline (Zoloft)</td>
<td>PO</td>
<td>Post-stroke depression (evidence-based; FLAME trial); first-line</td>
<td>25 mg daily; 50 mg daily; 100 mg daily; 150 mg daily :: PO :: :: Start 25 mg daily; increase by 25 mg every 1-2 weeks; typical 50-100 mg daily; max 200 mg</td>
<td>MAOIs; concurrent QT-prolonging drugs (high doses)</td>
<td>GI upset initially; bleeding risk with anticoagulants; sexual dysfunction</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Escitalopram (Lexapro)</td>
<td>PO</td>
<td>Post-stroke depression; well-tolerated in elderly</td>
<td>5 mg daily; 10 mg daily; 20 mg daily :: PO :: :: Start 5 mg daily in elderly; increase to 10 mg after 1 week; max 20 mg (10 mg if &gt;65y)</td>
<td>MAOIs; QT prolongation</td>
<td>QTc if cardiac risk; GI symptoms</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Citalopram (Celexa)</td>
<td>PO</td>
<td>Depression; agitation in dementia</td>
<td>10 mg daily; 20 mg daily :: PO :: :: Start 10 mg daily; max 20 mg in elderly due to QT prolongation risk</td>
<td>QT prolongation; concurrent QT-prolonging drugs</td>
<td>ECG at baseline if cardiac risk; QTc monitoring</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Mirtazapine (Remeron)</td>
<td>PO</td>
<td>Depression with poor appetite, weight loss, and insomnia</td>
<td>7.5 mg qHS; 15 mg qHS; 30 mg qHS :: PO :: :: Start 7.5-15 mg qHS; may increase to 30-45 mg qHS; lower doses more sedating</td>
<td>MAOIs; angle-closure glaucoma</td>
<td>Weight gain (often desired); sedation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Bupropion SR/XL</td>
<td>PO</td>
<td>Depression with fatigue and apathy; no sexual side effects; avoid if seizure risk</td>
<td>100 mg SR daily; 150 mg SR BID; 150 mg XL daily; 300 mg XL daily :: PO :: :: Start 100 mg SR daily or 150 mg XL daily; may increase after 3 days; max 400 mg/day</td>
<td>Seizure disorder; anorexia/bulimia; abrupt alcohol/benzo withdrawal</td>
<td>Seizure risk; insomnia; anxiety</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Methylphenidate</td>
<td>PO</td>
<td>Apathy refractory to antidepressants; psychomotor retardation</td>
<td>2.5 mg BID; 5 mg BID; 10 mg BID :: PO :: :: Start 2.5-5 mg BID (morning and noon); titrate by 2.5-5 mg every 3-5 days; max 30 mg/day</td>
<td>Severe hypertension; cardiac arrhythmias; hyperthyroidism; glaucoma</td>
<td>BP, HR; appetite; sleep</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Modafinil</td>
<td>PO</td>
<td>Apathy; fatigue; excessive daytime sleepiness</td>
<td>100 mg daily; 200 mg daily :: PO :: :: Start 100 mg each morning; may increase to 200 mg daily</td>
<td>Severe hepatic impairment; cardiac arrhythmias</td>
<td>BP, HR; sleep disturbance</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3e-behavioral-and-psychological-symptoms-of-dementia-bpsd">3E. Behavioral and Psychological Symptoms of Dementia (BPSD)<a class="headerlink" href="#3e-behavioral-and-psychological-symptoms-of-dementia-bpsd" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Trazodone</td>
<td>PO</td>
<td>Insomnia; sundowning; mild agitation</td>
<td>25 mg qHS; 50 mg qHS; 100 mg qHS; 150 mg qHS :: PO :: :: Start 25-50 mg qHS; titrate by 25-50 mg every 3-5 days; typical 50-150 mg qHS</td>
<td>MAOIs; significant QT prolongation</td>
<td>Orthostatic hypotension (fall risk); priapism (rare)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Melatonin</td>
<td>PO</td>
<td>Sleep disturbance; circadian rhythm dysfunction; sundowning</td>
<td>3 mg qHS; 6 mg qHS :: PO :: :: Start 3 mg qHS, 30 min before bed; may increase to 6 mg if needed</td>
<td>None significant</td>
<td>Daytime drowsiness</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Quetiapine (Seroquel)</td>
<td>PO</td>
<td>Severe agitation/psychosis when non-pharmacologic interventions fail</td>
<td>12.5 mg qHS; 25 mg qHS; 25 mg BID; 50 mg BID :: PO :: :: Start 12.5-25 mg qHS; titrate slowly; keep dose as low as possible</td>
<td>Black box: increased mortality and stroke in dementia; Parkinson's (less risk than others)</td>
<td>Metabolic effects; sedation; falls; QTc</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Risperidone (Risperdal)</td>
<td>PO</td>
<td>Severe aggression/psychosis (short-term use only)</td>
<td>0.25 mg BID; 0.5 mg BID; 1 mg BID :: PO :: :: Start 0.25 mg BID; increase by 0.25 mg BID weekly; max 1 mg BID; limit to 6-12 weeks</td>
<td>Black box: increased mortality and CVA in dementia</td>
<td>EPS, metabolic effects, stroke risk, prolactin</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Haloperidol</td>
<td>IM/IV/PO</td>
<td>Acute severe agitation in delirium-crisis only (avoid chronic use)</td>
<td>0.5 mg IM; 1 mg IM; 2 mg IM :: IM/IV/PO :: :: 0.5-2 mg IM/IV q4-6h PRN; short-term acute use only; avoid chronic use in dementia</td>
<td>QT prolongation; Parkinson's disease</td>
<td>QTc; EPS; akathisia</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Carbamazepine</td>
<td>PO</td>
<td>Agitation/aggression refractory to other treatments</td>
<td>100 mg BID; 200 mg BID :: PO :: :: Start 100 mg BID; titrate to 200-400 mg BID based on response; monitor levels</td>
<td>Bone marrow suppression; AV block</td>
<td>CBC; LFTs; Na; drug levels</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Dextromethorphan-quinidine (Nuedexta)</td>
<td>PO</td>
<td>Pseudobulbar affect (emotional lability) post-stroke</td>
<td>20/10 mg daily; 20/10 mg BID :: PO :: :: Start 20/10 mg daily x 7 days, then increase to 20/10 mg BID</td>
<td>MAOIs; concurrent quinidine; prolonged QT; complete heart block</td>
<td>QTc; drug interactions (quinidine inhibits CYP2D6)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<p><strong>Non-Pharmacologic Approaches (First-Line for BPSD):</strong>
- Identify and treat underlying causes (pain, infection, constipation, urinary retention)
- Environmental modifications (reduce noise, adequate lighting, consistent routine)
- Music therapy, reminiscence therapy, art therapy
- Structured activities appropriate to cognitive level
- Caregiver education on redirection and validation techniques
- Avoid confrontation; redirect instead</p>
<hr />
<h2 id="4-other-recommendations">4. OTHER RECOMMENDATIONS<a class="headerlink" href="#4-other-recommendations" title="Permanent link">&para;</a></h2>
<h3 id="4a-referrals-consults">4A. Referrals &amp; Consults<a class="headerlink" href="#4a-referrals-consults" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neurology/Cognitive neurology for diagnosis confirmation, differentiation from AD, and treatment planning</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Neuropsychology for formal cognitive testing to characterize executive dysfunction and memory profile</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Cardiology for atrial fibrillation management, anticoagulation decisions, and heart failure optimization</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Vascular surgery consultation for symptomatic carotid stenosis ≥50% to evaluate for endarterectomy</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Physical therapy for gait training, balance assessment, and fall prevention given motor involvement</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Occupational therapy for ADL assessment, cognitive strategies, and home safety evaluation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Speech therapy for communication strategies, cognitive-linguistic exercises, and swallowing evaluation if dysphagia</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Social work for caregiver support resources, community services, and long-term care planning</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Geriatric psychiatry for behavioral symptoms, depression management, and capacity evaluation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Registered dietitian for Mediterranean/DASH diet counseling and sodium restriction education</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Smoking cessation program with pharmacotherapy for current smokers</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Sleep medicine for obstructive sleep apnea evaluation and CPAP initiation if indicated</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Palliative care for advanced vascular dementia symptom management and goals of care discussions</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="4b-patient-instructions">4B. Patient Instructions<a class="headerlink" href="#4b-patient-instructions" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Call 911 immediately if new stroke symptoms develop (sudden weakness, speech difficulty, vision changes)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Return immediately if sudden worsening of confusion which may indicate new stroke, infection, or delirium</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Take all medications as prescribed especially antiplatelet/anticoagulant and statin which prevent further strokes</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Complete advance directives (living will, healthcare proxy, POLST) while patient has capacity</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Do not drive if cognitive impairment affects judgment or reaction time; formal driving evaluation may be needed</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Use pill organizers, alarms, or caregiver supervision to ensure medication adherence</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Check blood pressure at home regularly; notify provider if consistently &gt;140/90 or &lt;90/60</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Wear medical alert bracelet with diagnosis and emergency contact in case of wandering or emergency</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Keep environment safe: remove throw rugs, install grab bars, ensure adequate lighting, secure stove knobs</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<h3 id="4c-lifestyle-prevention">4C. Lifestyle &amp; Prevention<a class="headerlink" href="#4c-lifestyle-prevention" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Blood pressure target &lt;130/80 mmHg to reduce progression and prevent further strokes (SPRINT-MIND data)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>LDL target &lt;70 mg/dL with high-intensity statin for secondary vascular prevention</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Smoking cessation immediately; reduces stroke risk by 50% within 1 year of quitting</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Mediterranean or MIND diet emphasizing vegetables, berries, fish, whole grains, nuts, and olive oil</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Limit sodium to &lt;2300 mg/day (ideally &lt;1500 mg if hypertensive) to improve blood pressure control</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Limit alcohol to ≤1 drink daily as excess alcohol increases stroke risk and worsens cognition</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Regular aerobic exercise (150 min/week moderate intensity) to improve cardiovascular health and cognition</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Treat obstructive sleep apnea with CPAP as OSA worsens vascular risk and cognitive function</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Strict glycemic control (HbA1c &lt;7% or individualized 7-8% in frail elderly) to reduce microvascular damage</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Social engagement and cognitive stimulation to support cognitive reserve</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Weight management with target BMI 18.5-27 kg/m² (less stringent in elderly)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Fall prevention with home safety modifications and assistive devices as needed</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>CPAP compliance for sleep apnea patients to reduce nocturnal hypoxia and vascular events</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="section-b-reference">SECTION B: REFERENCE<a class="headerlink" href="#section-b-reference" title="Permanent link">&para;</a></h2>
<hr />
<h2 id="5-differential-diagnosis">5. DIFFERENTIAL DIAGNOSIS<a class="headerlink" href="#5-differential-diagnosis" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Alternative Diagnosis</th>
<th>Key Distinguishing Features</th>
<th>Tests to Differentiate</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alzheimer's disease</td>
<td>Insidious onset; gradual decline; memory predominant; no focal signs; no stepwise progression</td>
<td>MRI: hippocampal atrophy without significant WM disease; CSF Aβ42 low, p-tau elevated; amyloid PET positive</td>
</tr>
<tr>
<td>Mixed dementia (AD + VaD)</td>
<td>Features of both; memory impairment with vascular burden</td>
<td>Amyloid PET positive with significant WM disease; CSF biomarkers show AD pattern</td>
</tr>
<tr>
<td>Dementia with Lewy bodies</td>
<td>Visual hallucinations; parkinsonism; REM sleep behavior disorder; fluctuating cognition</td>
<td>DaTscan reduced; clinical criteria; may have less WM disease</td>
</tr>
<tr>
<td>Frontotemporal dementia (behavioral)</td>
<td>Personality/behavior changes; disinhibition; apathy; hyperorality; often age &lt;65</td>
<td>FDG-PET frontal hypometabolism; less vascular disease on MRI</td>
</tr>
<tr>
<td>Normal pressure hydrocephalus</td>
<td>Triad: gait disturbance (prominent), urinary incontinence, dementia; ventriculomegaly disproportionate to atrophy</td>
<td>MRI: ventriculomegaly with effaced sulci; high-volume LP with gait improvement</td>
</tr>
<tr>
<td>Chronic traumatic encephalopathy (CTE)</td>
<td>History of repetitive head trauma; mood and behavioral changes; no diagnostic test in life</td>
<td>History; clinical pattern; cavum septum pellucidum on MRI (suggestive)</td>
</tr>
<tr>
<td>CADASIL</td>
<td>Migraine with aura; early WM disease; family history; temporal pole and external capsule involvement</td>
<td>NOTCH3 genetic testing; skin biopsy showing GOM deposits</td>
</tr>
<tr>
<td>CNS vasculitis</td>
<td>Younger age; headache; encephalopathy; multifocal strokes; elevated inflammatory markers</td>
<td>Vessel wall MRI; DSA; brain/leptomeningeal biopsy</td>
</tr>
<tr>
<td>Creutzfeldt-Jakob disease</td>
<td>Rapid progression (weeks-months); myoclonus; periodic sharp waves on EEG; MRI DWI ribboning</td>
<td>CSF RT-QuIC; 14-3-3; EEG</td>
</tr>
<tr>
<td>Delirium superimposed on dementia</td>
<td>Acute change; fluctuating attention; identifiable precipitant (infection, medication, metabolic)</td>
<td>Treat cause; reassess cognition when clear</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="6-monitoring-parameters">6. MONITORING PARAMETERS<a class="headerlink" href="#6-monitoring-parameters" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Frequency</th>
<th>Target/Threshold</th>
<th>Action if Abnormal</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cognitive testing (MoCA)</td>
<td>Every 6-12 months</td>
<td>Establish baseline; track trajectory; MoCA assesses executive function</td>
<td>Adjust support; consider treatment changes</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Blood pressure</td>
<td>Each visit; daily at home</td>
<td>&lt;130/80 mmHg</td>
<td>Titrate antihypertensives; reduce if symptomatic hypotension</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>LDL cholesterol</td>
<td>Baseline, 6 weeks, then annually</td>
<td>&lt;70 mg/dL</td>
<td>Intensify statin; add ezetimibe or PCSK9 inhibitor</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>HbA1c</td>
<td>Baseline, then q3mo if diabetic</td>
<td>&lt;7% (7-8% if frail)</td>
<td>Optimize diabetes regimen</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Functional status (ADL/IADL, FAQ)</td>
<td>Every 6-12 months</td>
<td>Document for staging and care planning</td>
<td>Increase support services; OT referral</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Weight</td>
<td>Each visit</td>
<td>Stable; monitor for malnutrition</td>
<td>Nutritional consult; assess swallowing</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Neuropsychiatric symptoms (NPI)</td>
<td>Each visit</td>
<td>Monitor depression, apathy, BPSD</td>
<td>Non-pharmacologic first; consider medications</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>MRI Brain</td>
<td>Every 1-2 years or if new symptoms</td>
<td>Monitor WM disease progression; new infarcts</td>
<td>Optimize vascular risk factors; investigate new events</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>ECG/Cardiac rhythm</td>
<td>Annually or if symptomatic</td>
<td>Sinus rhythm; no new AF</td>
<td>Anticoagulation if AF detected</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Caregiver burden (Zarit scale)</td>
<td>Every 6-12 months</td>
<td>Early identification of burnout</td>
<td>Support resources; respite care</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Fall risk assessment</td>
<td>Each visit</td>
<td>Minimize fall risk</td>
<td>PT referral; home safety evaluation; assistive devices</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Driving status</td>
<td>Each visit</td>
<td>Safe for patient and community</td>
<td>Formal driving evaluation; DMV report if unsafe</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Creatinine/eGFR</td>
<td>Annually; with medication changes</td>
<td>Dose-adjust medications appropriately</td>
<td>Adjust ACE-I, metformin, anticoagulants</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="7-disposition-criteria">7. DISPOSITION CRITERIA<a class="headerlink" href="#7-disposition-criteria" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Disposition</th>
<th>Criteria</th>
</tr>
</thead>
<tbody>
<tr>
<td>Discharge home</td>
<td>Stable cognition; no acute stroke; safe environment; adequate caregiver support; outpatient follow-up arranged; reversible causes treated</td>
</tr>
<tr>
<td>Admit to floor</td>
<td>Acute delirium requiring workup; new stroke symptoms; behavioral crisis unsafe for home; aspiration pneumonia; falls with injury</td>
</tr>
<tr>
<td>Admit to stroke unit</td>
<td>New stroke with progression; recurrent TIAs; symptomatic carotid stenosis requiring urgent intervention</td>
</tr>
<tr>
<td>Admit to psychiatry</td>
<td>Severe behavioral disturbance requiring specialized psychiatric management; danger to self or others</td>
</tr>
<tr>
<td>Long-term care/Memory care</td>
<td>Progressive decline; caregiver unable to manage safely; wandering; 24-hour supervision needed</td>
</tr>
<tr>
<td>Hospice</td>
<td>End-stage vascular dementia; recurrent aspiration; weight loss; goals focused on comfort</td>
</tr>
<tr>
<td>Outpatient follow-up</td>
<td>Neurology every 3-6 months initially; every 6-12 months when stable; PCP for vascular risk factor management</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="8-evidence-references">8. EVIDENCE &amp; REFERENCES<a class="headerlink" href="#8-evidence-references" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th>Evidence Level</th>
<th>Source</th>
</tr>
</thead>
<tbody>
<tr>
<td>NINDS-AIREN criteria for vascular dementia diagnosis</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/8426677/">Roman et al. Neurology 1993</a></td>
</tr>
<tr>
<td>Cholinesterase inhibitors for vascular dementia (modest benefit)</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/17509485/">Kavirajan &amp; Schneider. Lancet Neurol 2007</a></td>
</tr>
<tr>
<td>Donepezil efficacy in vascular dementia</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/11809203/">Erkinjuntti et al. Lancet 2002</a></td>
</tr>
<tr>
<td>Galantamine for mixed AD/VaD</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/12849397/">Erkinjuntti et al. Lancet Neurol 2002</a></td>
</tr>
<tr>
<td>Memantine for vascular dementia</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/11935051/">Orgogozo et al. Stroke 2002</a></td>
</tr>
<tr>
<td>Intensive BP lowering reduces dementia risk (SPRINT-MIND)</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/30688979/">SPRINT MIND Investigators. JAMA 2019</a></td>
</tr>
<tr>
<td>High-intensity statin for secondary stroke prevention</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/16899775/">Amarenco et al. NEJM 2006 (SPARCL)</a></td>
</tr>
<tr>
<td>Antiplatelet therapy for secondary stroke prevention</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/11786451/">Antithrombotic Trialists. BMJ 2002</a></td>
</tr>
<tr>
<td>DOACs preferred over warfarin for AF-related stroke</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/24315724/">Ruff et al. Lancet 2014</a></td>
</tr>
<tr>
<td>Sertraline for post-stroke depression</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/21195350/">Chollet et al. Lancet Neurol 2011 (FLAME)</a></td>
</tr>
<tr>
<td>Mediterranean diet reduces dementia risk</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/16832238/">Scarmeas et al. Ann Neurol 2006</a></td>
</tr>
<tr>
<td>Physical exercise may slow cognitive decline</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/32738937/">Livingston et al. Lancet 2020 (Lancet Commission)</a></td>
</tr>
<tr>
<td>Avoid antipsychotics long-term in dementia (mortality risk)</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/16219884/">Schneider et al. JAMA 2005</a></td>
</tr>
<tr>
<td>CEA for symptomatic carotid stenosis 70-99%</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/1852179/">NASCET Collaborators. NEJM 1991</a></td>
</tr>
<tr>
<td>CPAP treatment improves cognition in OSA patients</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/25878183/">Osorio et al. Neurology 2015</a></td>
</tr>
<tr>
<td>CSF biomarkers help differentiate VaD from AD</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/26448651/">Skillback et al. Dement Geriatr Cogn Disord 2015</a></td>
</tr>
</tbody>
</table>
<hr />
<h2 id="change-log">CHANGE LOG<a class="headerlink" href="#change-log" title="Permanent link">&para;</a></h2>
<p><strong>v1.0 (January 27, 2026)</strong>
- Initial template creation
- NINDS-AIREN diagnostic framework
- Comprehensive vascular risk factor modification (BP, lipids, diabetes, smoking)
- Secondary stroke prevention with antiplatelet and anticoagulation therapies
- Cholinesterase inhibitors coverage (donepezil, rivastigmine, galantamine, memantine) with note on modest benefit
- Post-stroke depression management with SSRIs (sertraline first-line)
- Apathy treatment options (methylphenidate, modafinil, bupropion)
- BPSD management with non-pharmacologic approaches prioritized
- Differentiation from Alzheimer's and other dementias
- Structured dosing format for order sentence generation
- Focus on OPD setting with ED/HOSP coverage</p>
<hr />
<h2 id="appendix-a-ninds-airen-diagnostic-criteria-for-vascular-dementia">APPENDIX A: NINDS-AIREN Diagnostic Criteria for Vascular Dementia<a class="headerlink" href="#appendix-a-ninds-airen-diagnostic-criteria-for-vascular-dementia" title="Permanent link">&para;</a></h2>
<h3 id="probable-vascular-dementia-all-required">Probable Vascular Dementia (All Required)<a class="headerlink" href="#probable-vascular-dementia-all-required" title="Permanent link">&para;</a></h3>
<ol>
<li><strong>Dementia</strong> defined by cognitive decline from a previously higher level, manifested by:</li>
<li>Memory impairment AND</li>
<li>Impairment in two or more cognitive domains (orientation, attention, language, visuospatial, executive, motor control, praxis)</li>
<li>Deficits severe enough to interfere with ADLs</li>
<li>
<p>Not due to physical effects of stroke alone</p>
</li>
<li>
<p><strong>Cerebrovascular disease</strong> defined by:</p>
</li>
<li>Focal neurological signs consistent with stroke (hemiparesis, facial weakness, Babinski sign, sensory deficit, hemianopia, dysarthria) AND</li>
<li>
<p>Evidence of relevant CVD on neuroimaging (CT or MRI) including:</p>
<ul>
<li>Multiple large-vessel infarcts</li>
<li>Single strategically placed infarct (angular gyrus, thalamus, basal forebrain, PCA or ACA territory)</li>
<li>Multiple basal ganglia and white matter lacunes</li>
<li>Extensive periventricular white matter lesions</li>
<li>Combinations of the above</li>
</ul>
</li>
<li>
<p><strong>Relationship between dementia and CVD</strong> inferred by:</p>
</li>
<li>Onset of dementia within 3 months of recognized stroke OR</li>
<li>Abrupt deterioration in cognitive functions OR</li>
<li>Fluctuating, stepwise progression of cognitive deficits</li>
</ol>
<h3 id="features-consistent-with-diagnosis">Features Consistent with Diagnosis<a class="headerlink" href="#features-consistent-with-diagnosis" title="Permanent link">&para;</a></h3>
<ul>
<li>Early gait disturbance</li>
<li>History of unsteadiness and frequent falls</li>
<li>Early urinary frequency, urgency, and incontinence not explained by urological disease</li>
<li>Pseudobulbar palsy</li>
<li>Personality and mood changes (abulia, depression, emotional incontinence)</li>
<li>Preserved insight and judgment until late stages</li>
</ul>
<h3 id="features-making-diagnosis-uncertain">Features Making Diagnosis Uncertain<a class="headerlink" href="#features-making-diagnosis-uncertain" title="Permanent link">&para;</a></h3>
<ul>
<li>Early memory impairment with progressive worsening without imaging changes</li>
<li>Absence of focal neurological signs</li>
<li>Absence of CVD lesions on imaging</li>
</ul>
<hr />
<h2 id="appendix-b-neuroimaging-findings-in-vascular-dementia">APPENDIX B: Neuroimaging Findings in Vascular Dementia<a class="headerlink" href="#appendix-b-neuroimaging-findings-in-vascular-dementia" title="Permanent link">&para;</a></h2>
<h3 id="strategic-infarct-locations">Strategic Infarct Locations<a class="headerlink" href="#strategic-infarct-locations" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Location</th>
<th>Clinical Manifestation</th>
</tr>
</thead>
<tbody>
<tr>
<td>Thalamus (bilateral)</td>
<td>Severe amnesia, apathy, executive dysfunction</td>
</tr>
<tr>
<td>Angular gyrus (dominant)</td>
<td>Alexia, agraphia, anomia, Gerstmann syndrome</td>
</tr>
<tr>
<td>Anterior cerebral artery</td>
<td>Abulia, apathy, executive dysfunction</td>
</tr>
<tr>
<td>Posterior cerebral artery</td>
<td>Visual agnosia, amnesia (hippocampal involvement)</td>
</tr>
<tr>
<td>Basal ganglia (caudate)</td>
<td>Executive dysfunction, behavioral changes</td>
</tr>
<tr>
<td>Hippocampus</td>
<td>Anterograde amnesia</td>
</tr>
</tbody>
</table>
<h3 id="white-matter-disease-grading-fazekas-scale">White Matter Disease Grading (Fazekas Scale)<a class="headerlink" href="#white-matter-disease-grading-fazekas-scale" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Grade</th>
<th>Description</th>
<th>Clinical Implication</th>
</tr>
</thead>
<tbody>
<tr>
<td>0</td>
<td>Absent</td>
<td>Normal</td>
</tr>
<tr>
<td>1</td>
<td>Punctate foci</td>
<td>Mild; may be age-related</td>
</tr>
<tr>
<td>2</td>
<td>Beginning confluence of foci</td>
<td>Moderate; clinically significant</td>
</tr>
<tr>
<td>3</td>
<td>Large confluent areas</td>
<td>Severe; strongly associated with VaD</td>
</tr>
</tbody>
</table>
<h3 id="microbleed-distribution">Microbleed Distribution<a class="headerlink" href="#microbleed-distribution" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Pattern</th>
<th>Associated Condition</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lobar (cortical-subcortical)</td>
<td>Cerebral amyloid angiopathy</td>
</tr>
<tr>
<td>Deep (basal ganglia, thalamus)</td>
<td>Hypertensive microangiopathy</td>
</tr>
<tr>
<td>Mixed</td>
<td>Both pathologies may coexist</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="appendix-c-differentiating-vascular-dementia-from-alzheimers-disease">APPENDIX C: Differentiating Vascular Dementia from Alzheimer's Disease<a class="headerlink" href="#appendix-c-differentiating-vascular-dementia-from-alzheimers-disease" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Feature</th>
<th>Vascular Dementia</th>
<th>Alzheimer's Disease</th>
</tr>
</thead>
<tbody>
<tr>
<td>Onset</td>
<td>Abrupt or stepwise</td>
<td>Insidious, gradual</td>
</tr>
<tr>
<td>Progression</td>
<td>Stepwise or fluctuating</td>
<td>Gradual, continuous</td>
</tr>
<tr>
<td>Memory</td>
<td>Variable; may be preserved early</td>
<td>Prominent early memory loss</td>
</tr>
<tr>
<td>Executive function</td>
<td>Prominently impaired</td>
<td>Impaired later</td>
</tr>
<tr>
<td>Focal neurological signs</td>
<td>Often present</td>
<td>Usually absent</td>
</tr>
<tr>
<td>Gait disturbance</td>
<td>Early and prominent</td>
<td>Late feature</td>
</tr>
<tr>
<td>Incontinence</td>
<td>Early</td>
<td>Late</td>
</tr>
<tr>
<td>MRI findings</td>
<td>Strategic infarcts, WM disease, lacunes</td>
<td>Hippocampal/MTL atrophy</td>
</tr>
<tr>
<td>Amyloid PET</td>
<td>Negative (or positive if mixed)</td>
<td>Positive</td>
</tr>
<tr>
<td>CSF Aβ42</td>
<td>Normal</td>
<td>Low</td>
</tr>
<tr>
<td>CSF p-tau</td>
<td>Normal or mildly elevated</td>
<td>Elevated</td>
</tr>
<tr>
<td>Response to ChEIs</td>
<td>Modest</td>
<td>More robust</td>
</tr>
<tr>
<td>Vascular risk factors</td>
<td>Prominent</td>
<td>May be present</td>
</tr>
</tbody>
</table>
<p><strong>Note:</strong> Mixed dementia (AD + VaD) is common, especially in elderly patients. Look for features of both pathologies.</p>







  
  






                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
        
<div class="md-social">
  
    
    
    
    
      
      
    
    <a href="https://github.com/blondarb/neuro-plans" target="_blank" rel="noopener" title="github.com" class="md-social__link">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    
      
      
      <script id="__config" type="application/json">{"annotate": null, "base": "../..", "features": ["navigation.instant", "navigation.tracking", "navigation.sections", "navigation.expand", "navigation.top", "search.suggest", "search.highlight", "content.code.copy"], "search": "../../assets/javascripts/workers/search.2c215733.min.js", "tags": null, "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}, "version": null}</script>
    
    
      <script src="../../assets/javascripts/bundle.79ae519e.min.js"></script>
      
        <script src="../../assets/js/comments.js"></script>
      
    
  </body>
</html>